Rejection of pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) by low pressure reverse osmosis membranes

Water Science and Technology

Volumn 58, Issue 1, 2008, Pages 73-81

  Ozaki, H ^a   Ikejima, N ^b   Shimizu, Y ^b   Fukami, K ^a   Taniguchi, S ^a   Takanami, R ^a   Giri, R R ^b   Matsui, S ^b  

^a OSAKA SANGYO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Diffusion coefficient; Dissociation degree; EDCs; Hydrophobicity; LPRO membrane; PPCPs

Indexed keywords

ADSORPTION; CHEMICALS; ORGANIC POLYMERS; OSMOSIS; POLYMERS; REVERSE OSMOSIS; WATER POLLUTION;

DIFFUSION COEFFICIENT; DISSOCIATION DEGREE; EDCS; HYDROPHOBICITY; LPRO MEMBRANE; PPCPS;

OSMOSIS MEMBRANES;

2,4 DICHLOROPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; CARBAMAZEPINE; CARBOXYL GROUP; CHEMICAL AGENT; CLOFIBRIC ACID; CROTAMITON; DICLOFENAC; DIETHYLTOLUAMIDE; ENDOCRINE DISRUPTOR; ESTRADIOL; GEMFIBROZIL; HYDROXYL GROUP; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NONYLPHENOL; PHARMACEUTICAL AND PERSONAL CARE PRODUCT; PHENACETIN; PHTHALIC ACID DIETHYL ESTER; POLYAMIDE; PROPYPHENAZONE; TRICLOSAN; UNCLASSIFIED DRUG;

ADSORPTION; DRUG; ENDOCRINE DISRUPTOR; HYDROPHOBICITY; MEMBRANE; OSMOSIS; RETENTION;

ACIDITY; ADSORPTION; ARTICLE; DIFFUSION COEFFICIENT; DIPOLE; DISSOCIATION; HYDROPHOBICITY; LOW PRESSURE REVERSE OSMOSIS MEMBRANE; MEMBRANE FILTER; PH; SOLUTE; THERMODYNAMICS; WASTE WATER MANAGEMENT; WATER POLLUTANT;

ADSORPTION; CHROMATOGRAPHY, GEL; ENDOCRINE DISRUPTORS; EQUIPMENT DESIGN; HOUSEHOLD PRODUCTS; HUMANS; HYDROGEN-ION CONCENTRATION; MEMBRANE POTENTIALS; OSMOSIS; PHARMACEUTICAL PREPARATIONS; ULTRAFILTRATION; URBAN POPULATION; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION; WATER SUPPLY;

EID: 50849119727     PISSN: 02731223     EISSN: None     Source Type: Book Series    
DOI: 10.2166/wst.2008.607     Document Type: Article

References (15)

1. Agenson, K. O., Oh, J. & Urase, T. 2003 Retention of a wide variety of organic pollutants by different nanofiltration/reverse osmosis membranes: controlling parameters of process. J. Membr. Sci. 225(1-2), 91-103.
2. Bellona, C., Drewes, J. E. & Amy, G. 2004 Factors affecting the rejection of organic solutes during NF/RO treatment: a literature review. Water Res. 38(12), 2795-2809.
3. Braeken, L., Bettens, B., Boussu, K., Meeren, P. V., Cocquyt, J., Vermant, J. & Bruggen, B. V. 2006 Transport mechanisms of dissolved organic compounds in aqueous solution during nanofiltration. J. Membr. Sci. 279(1-2), 311-319.
4. a) in physiological resembling conditions. A case study: Ionizable non-steroidal anti-inflammatory drugs. http://www.biochempress.com/iecmd_2004_05.html (accessed on September 13th 2007).
5. Kimura, K., Toshima, S., Amy, G. & Watanabe, Y. 2004 Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes. J. Membr. Sci. 245(1-2), 71-78.
6. Kiso, Y., Kitano, T., Jinno, K. & Miyagi, M. 1992 The effects of molecular width on permeation of organic solute through cellulose acetate reverse osmosis membranes. J. Membr. Sci. 74, 95-103.
7. Nghiem, L. D. & Schafer, A. I. 2005 Nanofiltration of hormone mimicking trace organic compounds. Sep. Sci. Technol. 40, 2633-2649.
8. Nghiem, L. D., Shaefer, A. I. & Elimelech, M. 2006 Role of electrostatic interactions in the retention of pharmaceutically active contaminants by a loose nanofiltration membrane. J. Membr. Sci. 286, 52-59.
9. Ozaki, H. & Li, H. 2002 Rejection of organic compounds by ultra-low pressure reverse osmosis membrane. Water Res. 36, 123-130.
10. Ozaki, H., Ikejima, N., Matsui, S., Terashima, Y., Takeda, S., Tari, I. & Li, H. 2002 The role of membrane (-potential in solute rejection by low pressure reverse osmosis. Water Sci. Technol. Water Supply 2(5-6), 321-328.
11. Pronk, W., Palmquist, H., Biebow, M. & Boller, M. 2006 Nanofiltration for the separation of pharmaceuticals from nutrients in source-separated urine. Water Res. 40(7), 1405-1412.
12. Snyder, S. A., Westerhoff, P., Yoon, Y. & Sedlak, D. L. 2003 Pharmaceuticals, personal care products and endocrine disruptors in water: implications for the water industry. Environ. Eng. Sci. 20(5), 449-469.
13. Urase, T. & Sato, K. 2007 The effect of deterioration of nanofiltration membrane on retention of pharmaceuticals. Desalination 202, 385-391.
14. Van der Bruggen, B., Braeken, L. & Vandecasteele, C. 2002 Evaluation of parameters describing flux decline in nanofiltration of aqueous solutions containing organic compounds. Desalination 147, 281-288.
15. Yoon, Y., Westerhoff, P., Snyder, S. A. & Wert, E. C. 2006 Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products. J. Membr. Sci. 270, 88-100.